shows that one of three adult Americans has HTN. Moreover, HTN is a known risk factor for incident cardiovascular disease, which include stroke, coronary and peripheral artery disease, and heart failure. 1 In particular, development of left ventricle (LV) hypertrophy in HTN predicts poor cardiovascular prognosis. 2, 3 Growing evidence demonstrates that regression of LV hypertrophy results in improved prognosis, 4,5 and can be achieved with medical therapy such as angiotensin-converting enzyme inhibitors, which can prevent progression and induce regression of LV hypertrophy. In addition to a decrease in blood pressure, such drugs may attenuate LV hypertrophy by direct mechanisms, such as neurohumoral mechanisms, 4 direct antihypertrophic, 6,7 and antifibrotic 8,9 effects on the myocardium, and an antiproliferative effect on vascular smooth muscle. 10 In addition to LV hypertrophy, HTN also affects microvascular structure and function. 11 Our previous studies demonstrated that HTN altered coronary microvascular permeability (MP) and fractional vascular volume (FVV), important indices of microvascular structure and function, 12,13 blunted myocardial perfusion responses to challenge, 11,13 and induced coronary microvascular proliferation. 14 Coronary microvascular dysfunction can modulate coronary artery resistance and myocardial blood flow, 15 which may lead to episodes of myocardial ischemia. This in turn can lead to compensatory BACkgROuNd Hypertension (HTN) may lead to left ventricular hypertrophy and vascular dysfunction, which are independent factors for adverse cardiovascular outcomes. We hypothesized that decreased blood pressure by percutaneous transluminal renal angioplasty (pTra) would improve the function and architecture of coronary microvessels, in association with decreased inflammation and fibrosis.
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Hypertension and Microvascular Dysfunction neovascularization by modifying the expression of tissue oxygen sensors like prolyl hydroxylase domain-containing proteins (PHD), hypoxia-inducible factor (HIF)-1α, and von Hippel-Lindau (VHL) tumor suppressor protein. Interestingly, early HTN is associated with increased expression of HIF-1α and vascular endothelial growth factor (VEGF), 14 which promote new vessel formation. 16 However, these new microvessels are frequently abnormal, thin-walled, and have increased permeability 17 which could eventually lead to tissue damage. Indeed, microvascular dysfunction is associated with increased levels of inflammatory markers like tumor necrosis factor-α (TNF-α), 16 decreased endothelial nitric oxide synthase (eNOS) expression, 18 and increased myocardial fibrosis. 16, 19 We have recently shown in an experimental model of renovascular HTN that percutaneous transluminal renal angioplasty (PTRA) can restore normal blood pressure. 20 However, the potential of a selective decrease in blood pressure alone, devoid of myocardial and vascular pleiotropic effects, to reverse cardiac dysfunction remains unclear. This study tested the hypothesis that decreased blood pressure by PTRA would improve the function and architecture of coronary microvessels, in association with decreased inflammation and fibrosis.
METhOdS
Experimental protocol. This study was approved by the Institutional Animal Care and Use Committee. Twenty-two female domestic pigs (45-60 kg) were studied after 10 weeks of observation. In 15 pigs, renovascular HTN was induced at baseline by a local-irritant coil placed in the main renal artery, [21] [22] [23] [24] then a telemetry system (Data Sciences International, Arden Hills, MN) was implanted in the left femoral artery to continuously monitor mean arterial pressure (MAP), as previously described. 21, 23, 24 For this purpose, all the pigs were anesthetized with an intramuscular injection of telazol (5 mg/kg) and xylazine (2 mg/kg), intubated, and mechanically ventilated with room air. Anesthesia was maintained with a mixture of ketamine (0.2 mg/kg/min) and xylazine (0.03 mg/kg/min) in normal saline (0.05 µl/kg/min).
After 6 weeks of renovascular HTN, the pigs were anesthetized again and randomized into two groups: sham-treatment (HTN, n = 7) or PTRA and stenting (HTN + PTRA, n = 8). Seven normal pigs served as control group. The degree of stenosis was evaluated by selective renal angiography, followed by PTRA or sham procedure. A 7F balloon catheter with a balloon-expandable stent was engaged in the proximal-middle section of the renal artery under fluoroscopic guidance and the balloon was inflated, resulting in expansion of a tantalum stent to full balloon diameter and restored luminal opening. Then, the balloon was deflated and removed, leaving the stent embedded in the vascular wall.
Four weeks later the pigs were again anesthetized similarly. Blood samples were collected from the inferior vena cava for measurement of plasma renin activity (radioimmunoassay), 25 aldosterone, and TNF-α. Then multidetector-computed tomography (CT) studies were performed to assess cardiac function and structure in vivo, coronary MP and FVV (before and after adenosine, 400 µg/kg/min IV), LV muscle mass, and systolic and diastolic cardiac function. 14, 16, 26 A few days after completion of all functional studies, the pigs were euthanized using pentobarbital (100 mg/kg), and LV anterior wall tissue harvested for in-vitro studies. LV myocardial segments were fresh frozen or preserved in formalin, and another segment prepared for micro-CT studies.
Microvascular architecture was assessed by evaluation of microvascular density and tortuosity by micro-CT, mediato-lumen ratio, and myocyte cross-sectional area were evaluated using hematoxylin-eosin stained slides, and myocardial fibrosis by trichrome staining. 12 In addition, coronary microvascular eNOS immunoreactivity was determined as an index of nitric oxide availability. Tissue oxygen sensors were evaluated by the myocardial expression of PHD, HIF-1α, and VHL, whereas myocardial expression of TNF-α, cyclooxygenase (COX)-1 and -2, VEGF, and its receptor (FLK-1), were assessed to evaluate myocardial inflammation and angiogenic activity.
Cardiac data analysis. The images were analyzed with the Analyze software package (Biomedical Imaging Resource; Mayo Clinic, Rochester, MN). LV endocardial and epicardial surfaces were traced at end-diastole and end-systole for evaluation of systolic function. The ejection fraction, stroke volume, and LV muscle mass were calculated as previously described. 13, 16, 19 Diastolic function was assessed from changes in the volume of the total LV cavity throughout the cardiac cycle. Early (E) and late (A) LV filling rate were obtained from the positive slopes of the curve and E/A ratio calculated, as described before. 12, 19 In addition, regions of interest were manually traced at enddiastole in the cardiac anterior wall. The time-density data were then used to assess MP (arbitrary units) and FVV (%) based on the Patlak graphical analysis method. 12, 26 Micro-CT analysis. The left anterior descending artery was perfused with a radio-opaque silicone polymer (Microfil MV122; Flow Tech, Carver, MA) and myocardial samples scanned using a micro-CT scanner, as previously described. 12, 14, 16, 19 The spatial density of subepicardial and subendocardial microvessels, and tortuosity of transmural, tomographically isolated microvessels, were then calculated.
Immunohistochemistry and western blotting. In-vitro studies were performed to assess mechanisms responsible for formation and maintenance of the coronary microvasculature, as well as hypoxic and inflammatory factors. Standard western blotting protocols were followed 27 using total homogenates and specific antibodies against HIF-1α, TNF-α (1:200; Abcam, Cambridge, MA), PHD, VHL, COX-1, COX-2, VEGF, FLK-1 (all, 1:200; Santa Cruz Biotechnology, Santa Cruz, CA). GAPDH was used as loading control.
Staining was performed in 5-µm paraffin slides for H&E, α-smooth muscle actin, eNOS, and Masson trichrome, following standard procedures. 12 Each representative staining original contributions
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was quantified semiautomatically in 10-15 random fields, and expressed as percentage of staining of total surface area using a computer aided image analysis program (MetaMorph; Molecular Devices, Sunnyvale, CA). Myocyte cross-sectional area and media-to-lumen ratio were evaluated as previously described. 12 Statistical analysis. Quantitative data are expressed as mean ± s.e.m. Statistical comparisons among different experimental groups or studies were performed using analysis of variance, and paired or unpaired t-test with the Bonferroni correction. Statistical significance was accepted for P ≤ 0.05.
RESulTS
Six weeks after induction of renal artery stenosis, the degree of stenosis was similar in HTN and HTN+PTRA (67.6 ± 9.5 vs. 67.1 ± 5.4%, P = 0.97), and their MAP was similarly (P = 0.36) elevated compared to normal (118.1 ± 8.6, 122.7 ± 9.4, and 92.3 ± 3.4 mm Hg, respectively, both P < 0.01 vs. normal). The pigs were then randomized to PTRA or sham, and 4 weeks later MAP remained significantly elevated only in untreated HTN pigs ( Table 1 , P < 0.001 vs. normal). Two HTN+PTRA pigs were excluded due to restenosis, whereas in the remaining pigs (n = 6) PTRA significantly decreased MAP (P < 0.01 vs. HTN, Table 1 and Figure 1 ). Plasma renin activity was similar among the groups ( Table 1) , whereas aldosterone was elevated in HTN (P = 0.03 vs. normal), but not in HTN+PTRA (P = 0.33 vs. normal; P = 0.07 vs. HTN, Table 1 ). There were no significant differences in body weight among the groups at either 6 or 10 weeks after induction of renal artery stenosis.
The heart rate and stroke volume were similar among the groups. LV muscle mass that increased in HTN compared to normal was decreased by PTRA (P < 0.003 and P = 0.02, 
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Hypertension and Microvascular Dysfunction respectively, Table 1 ), indicating reversed myocardial hypertrophy. E/A ratio significantly decreased in HTN compared to normal controls ( Table 1 , P = 0.002), whereas in the PTRA group the E/A-ratio was restored (P = 0.005 vs. HTN), suggesting that diastolic dysfunction in HTN was blunted by PTRA.
Coronary microvascular function
Compared to normal, basal MP was significantly increased in HTN (P = 0.04, Figure 2a ), but not in HTN+PTRA (P = 0.36). Adenosine induced in HTN a significant increase in MP compared to baseline and to normal (P = 0.01 for both), whereas in HTN+PTRA MP remained similar to normal and did not increase (Figure 1b) . Basal FVV was similar among the groups (Figure 2b) . Adenosine significantly increased FVV in normal but not in HTN pigs, and the response to adenosine was significantly attenuated in HTN compared to normal (P = 0.04, Figure 2c) . In HTN+PTRA FVV did not increase compared to baseline, but the degree of response was not different than normal (P = 0.3). These data indicate that decreased MAP by PTRA improved microvascular response to adenosine.
Microvascular density
HTN selectively increased the subepicardial density of coronary microvessels 20-200 µm in diameter compared to normal (P = 0.01, Figure 3a,c) , whereas in HTN+PTRA microvascular density was similar to normal (P = 0.5) and decreased compared to HTN (P = 0.006, Figure 3a,c) . In addition, microvascular tortuosity (indicative of angiogenic vessels) that was increased in HTN (P = 0.007 vs. normal) significantly improved after PTRA (P = 0.04 vs . HTN, Figure 3b,c) . The average diameters of these microvessels were similar in among the groups ( Table 1) .
Myocardial structure and protein expression of oxygen sensors, inflammatory, and angiogenic factors
The expression of HIF-1α in the myocardium increased in HTN compared to normal (P = 0.007 Figure 4a,b) , and decreased in HTN+PTRA (P = 0.002). Contrarily, the expression of VHL and PHD was downregulated only in hypertensive pigs, suggesting some tissue hypoxia. Systemic TNF-α was similar among the groups ( The subendocardial (white bars) density of microvessels (<200 µm in diameter) was similar among the groups, whereas subepicardial (black bars) density and tortuosity increased in HTN, but were restored after a decrease in blood pressure. *P ≤ 0.05 vs. normal, † P ≤ 0.05 vs. HTN+pTra.
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Hypertension and Microvascular Dysfunction expression of COX-2, while the constitutive form Cox-1 expression remained similar among groups (Figure 3a,b) . These data suggest that PTRA decreased the expression of inflammatory mediators. VEGF expression was similarly increased in HTN and HTN+PTRA compared to normal (P = 0.03 and P = 0.01, respectively, Figure 4) , while its receptor FLK-1 was upregulated only in HTN (P = 0.03 vs. normal), suggesting mild attenuation of angiogenic signaling by reversal of HTN.
Myocyte cross-sectional area was greater in HTN compared to both normal (P < 0.001) and HTN+PTRA (P = 0.03, Figure 5a ) indicating that PTRA reversed myocardial hypertrophy. Media to lumen ratio increased only in HTN compared to normal (0.66 ± 0.07 and 0.48 ± 0.04, respectively, P = 0.02), but not in HTN+PTRA (P = 0.55 ± 0.03, P = 0.22 vs. normal, and P = 0.12 vs. HTN). eNOS significantly decreased only in HTN (P < 0.05 vs. normal, Figure 5b) , while trichrome staining showed increased myocardial interstitial fibrosis in both HTN and HTN+PTRA (P < 0.001 and P < 0.01, respectively vs. normal), although in PTRA pigs the fibrosis was attenuated compared to HTN (P = 0.03 vs. HTN, Figure 5c) . dISCuSSION The present study shows that PTRA decreased blood pressure, improved coronary microvascular function and architecture, and prevented left ventricular hypertrophy, in association with improvement in diastolic function. These changes were accompanied by reduced expression of hypoxia-induced proteins, inflammatory and angiogenic factors, and enhanced eNOS expression. Our study therefore demonstrates that PTRA in swine experimental renovascular HTN improved HTN-induced microvascular dysfunction and proliferation. On the other hand, fibrosis was not fully abolished, suggesting that resolution of structural damage lags behind restoration of cardiac function after reversal of HTN.
In the United States about 74.5 millions of adults people have high blood pressure, potentially leading to LV hypertrophy 2,3 and coronary microvascular dysfunction, [28] [29] [30] [31] which are independent risk factor for adverse cardiovascular outcomes. Medical treatment of HTN has been shown to cause regression of LV hypertrophy, 32, 33 but commonly confers additional benefits independently of the blood pressure reduction. 4 Thus, the potential advantage for the coronary microcirculation of 
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We have recently shown that PTRA successfully decreased blood pressure in experimental renovascular HTN. 20 In our experimental swine model, blood pressure increased a few days after implantation of a local-irritant coil in the main renal artery and induced coronary microvascular dysfunction. 14, 16 Plasma renin activity is typically not elevated in the chronic phase of untreated renovascular HTN, 34 while aldosterone may remain increased. 12 The present study shows that HTN increased coronary MP and decreased FVV response to adenosine, an endothelium-dependent and -independent vasodilator. Effective PTRA induced a rapid and stable decrease of arterial pressure, and by 4 weeks later, both coronary MP and FVV response to adenosine improved.
The decreased response of FVV to adenosine could be due to microvascular dysfunction. Impaired coronary microvascular function is often accompanied by decreased vasodilator activity 18, 35 and increased inflammation. 12 Indeed, we observed reduced eNOS expression in HTN, which may lead to decreased nitric oxide bioavailability and decrease coronary response to adenosine. In addition, while systemic TNF-α was within normal values, its myocardial expression increased only in HTN pig, as was the inducible enzyme COX-2 (despite the unchanged expression of the constitutive COX-1), indicating myocardial inflammation. Importantly, 4 weeks after PTRA, myocardial expression of eNOS was significantly higher, TNF-α and COX-2 was significantly lower than HTN, implying increased nitric oxide production and decreased inflammation associated with improved coronary microvascular function.
HTN and coronary microvascular dysfunction may lead to episodes of myocardial ischemia, 14, 16, 36, 37 and thereby increased the expression of HIF1-α. Indeed, we have previously shown that HIF-1α expression increased in association with coronary microvascular dysfunction. 38 HIF-1α is primarily regulated by PHDs that initiate is degradation via VHL. 39 During ischemic conditions HIF-1α degradation is inhibited and its transcription increases. 40, 41 This study extends our previous observations and shows that increased myocardial expression of HIF-1α and decreased PHD/VHL in HTN normalized after reversal of HTN, which may suggest decreased myocardial ischemic episodes secondary to decreased blood pressure and improved coronary vascular function.
The decrease in HIF-1α after normalization of blood pressure is consistent with the decrease in myocardial microvascular 
Hypertension and Microvascular Dysfunction density and tortuosity, which are characteristic of angiogenic vessels. VEGF, the HIF1-α target gene, is a key angiogenic factor, which acts mainly through its receptor Flk-1. Although VEGF expression that increased in HTN remained elevated in HTN+PTRA, the increased myocardial expression of Flk-1 in HTN decreased after PTRA, which might have contributed to the decrease in microvascular density. These data suggested that regulation of vascular density after reversal of HTN may be initially achieved at the levels of the FLK-1 receptor expression, rather that the VEGF ligand. HTN induces myocyte hypertrophy and interstitial fibrosis, which in turn increase cardiac stiffness and impair diastolic function. In this study, decreased arterial pressure and after load alleviated microvascular remodeling (e.g., mediato-lumen ratio) and cardiac diastolic dysfunction, likely by reducing stretch-and inflammation-induced myocardial hypertrophy and fibrosis, thereby ameliorating cardiac stiffness and increasing compliance. Nevertheless, myocardial interstitial fibrosis has not been fully cleared and thus remained higher than normal.
Our study was limited by the use of relatively young pigs without additional comorbid conditions, and by a short duration of HTN relative to the human disease. In addition, future studies will need to determine whether myocardial fibrosis fully regresses after longer observation periods following reversal of HTN. Nevertheless, coronary microvascular structure and function in the swine model are similar to human, and their improvement upon normalization of blood pressure underscores the significant direct pathophysiologic effect of HTN on the coronary microvasculature and the myocardium. Alas, we cannot rule out the contribution of humoral or other factors secondary to the change in blood pressure to the improvement observed in microvascular function and architecture.
In conclusion, the present study shows that direct reversal of chronic porcine renovascular HTN reduced evidence of myocardial ischemic insults, improved coronary microvascular function and architecture, and reversed myocardial hypertrophy and diastolic dysfunction. Myocardial interstitial fibrosis was partly resolved. These observations underscore the benefits of normalization of blood pressure to preserve cardiovascular function and structure. acknowledgment: This work was supported in part by NiH grants Hl085307, DK73608, Hl77131, and DK73013.
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